Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
About this study
A pragmatic electronic health record (EHR) based randomized controlled trial to evaluate the utility of providing Ultromics EchoGo analysis results and recommendations for HF risk prevention therapies using an EHR embedded clinical decision support tool.
- Condition
- Heart Failure, Diabetes
- Tested
- Message with EchoGo, Standard Message
- Sponsor
- University of Texas Southwestern Medical Center
Who can join
- Age
- Not specified
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 4
- Study condition: Heart Failure, Diabetes
- Clinical cohort inclusion exclusion criteria:
- Patients with diagnosis of Type 2 diabetes and High WATCH DM score.
- Echocardiogram available in last 6-months.
Exclusion 3
- History of HF
- Not eligible for prescription of new GLP-1RA or SGLT2i or ns-MRA
- Corresponding providers to patients identified by the above inclusion exclusion criteria will be included in the clinical trial of the decision support tool.
Where
1 site, 1 recruiting
UT Southwestern Medical Center
Dallas, Texas, United States
Contact
-
Ambarish Pandey, MD
617-869-8957 Ambarish.Pandey@UTSouthwestern.edu
Potential match only. Final eligibility is determined by the study team.